Regal Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Regal Investment Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,385	Closed	-$91K	–	718
2015 Q3	$91K	Buy	1,385 +345	+33%	+$26.8K	0.02%	356
2015 Q2	$81K	Hold	1,040	–	–	0.02%	365
2015 Q1	$79K	Hold	1,040	–	–	0.02%	371
2014 Q4	$69K	Sell	1,040 -617	-37%	-$41.1K	0.02%	359
2014 Q3	$105K	Hold	1,657	–	–	0.03%	297
2014 Q2	$101K	Hold	1,657	–	–	0.04%	278
2014 Q1	$94K	Hold	1,657	–	–	0.04%	267
2013 Q4	$89K	Hold	1,657	–	–	0.05%	225
2013 Q3	$76K	Hold	1,657	–	–	0.04%	261
2013 Q2	$70K	Buy	+1,657	New	+$69K	0.04%	266

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Regal Investment Advisors's PJP Position: Q4 2015 in Review

Regal Investment Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2015, closing a stake of 1,385 shares — an estimated $91K sold.

Regal Investment Advisors first reported a position in PJP in Q2 2013 and held it in 10 quarters. The position peaked at $105K in Q3 2014. 112 funds tracked by Wall St. Rank hold PJP as of Q4 2015.

Regal Investment Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Regal Investment Advisors sold 1,385 Invesco Pharmaceuticals ETF shares in Q4 2015, an estimated $91K.
Regal Investment Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
Regal Investment Advisors's Invesco Pharmaceuticals ETF position peaked at $105K in Q3 2014.
112 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2015.

Based on Regal Investment Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.